Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease ; volume:15 ; number:1 ; day:14 ; month:2 ; year:2024 ; pages:1-8 ; date:12.2024
Insights into imaging ; 15, Heft 1 (14.2.2024), 1-8, 12.2024
- Urheber
-
Jeon, Sun Kyung
Lee, Jeong Min
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13244-024-01611-0
- URN
-
urn:nbn:de:101:1-2404221209179.355380896002
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jeon, Sun Kyung
- Lee, Jeong Min
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content
Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children
Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1
Betaine in ameliorating alcohol-induced hepatic steatosis
Melatonin: a potential intervention for hepatic steatosis
Role of SCAP/SREBP in Hepatic Steatosis
Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease
Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content
Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children
Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1
Betaine in ameliorating alcohol-induced hepatic steatosis
Melatonin: a potential intervention for hepatic steatosis
Role of SCAP/SREBP in Hepatic Steatosis
Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease
Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content
Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children
Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1
Betaine in ameliorating alcohol-induced hepatic steatosis
Melatonin: a potential intervention for hepatic steatosis
Role of SCAP/SREBP in Hepatic Steatosis
Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease
Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease